GI Oncology Commercial Training Program
The Challenge
As treatment landscapes evolved and new clinical trial data emerged across multiple GI oncology indications, commercial teams needed timely education on disease-state fundamentals, treatment pathways, biomarkers, outcomes data, and competitor positioning.
The challenge was translating large volumes of complex oncology information into clear, scientifically accurate learning resources that could support field readiness, knowledge retention, and ongoing commercial training objectives across a rapidly changing therapeutic landscape.
Project Overview
Audiences
Stakeholders
My Role
Key
Deliverables
Communication Focus
-
Sales representatives
-
Medical affairs teams (medical science liaisons)
-
Commercialization & sales training leaders
-
Marketing teams
-
Medical, legal, & regulatory (MLR) reviewers
-
Cross-functional agency & account teams
Developed product training and competitive intelligence materials supporting GI oncology commercial training initiatives. Synthesized clinical trial data, biomarkers, mechanisms of action, treatment pathways, and competitive landscape information into structured learning experiences designed to support field readiness and stakeholder-facing discussions.
eLearning modules, interactive eBooks, print modules, LMS-compatible certification, and knowledge assessments
-
GI tumor executive summary
-
HCC indication and BTC indication backgrounders
-
Competitive landscape modules
-
Pivotal clinical trial summaries
-
Product backgrounders
-
Mechanism-of-action summaries
-
Certification assessments
-
Treatment landscapes
-
Translating complex oncology science into field-ready training content
-
Equipping teams for stakeholder-facing discussions in a competitive treatment landscape
-
Synthesizing clinical evidence into clear, actionable messaging
-
Structuring content for rapid comprehension and knowledge retention
-
Balancing scientific rigor with usability
-
Aligning communications with commercial and medical priorities